FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4391611000001108: Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1737661000001117 Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1737671000001110 Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Is a Imipenem 500mg / Cilastatin 500mg powder for solution for injection vials true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has active ingredient Cilastatin sodium false Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has active ingredient Imipenem monohydrate false Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Is a Primaxin I.V. true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Imipenem true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cilastatin true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has specific active ingredient Cilastatin sodium false Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has specific active ingredient Imipenem monohydrate false Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has active ingredient Imipenem true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has active ingredient Cilastatin true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has manufactured dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has specific active ingredient Imipenem monohydrate true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has basis of strength substance Imipenem true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has basis of strength substance Cilastatin true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has specific active ingredient Cilastatin sodium true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Is pack of False Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has AMP True Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start